Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - Emmaus Life Sciences, Inc. | s105694_ex31-2.htm |
EX-31.1 - EXHIBIT 31.1 - Emmaus Life Sciences, Inc. | s105694_ex31-1.htm |
10-Q/A - 10-Q/A - Emmaus Life Sciences, Inc. | s105694_10qa.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the amended Quarterly Report on Form 10-Q/A for the quarter ended December 31, 2016 (the “Report”) by MYnd Analytics, Inc.. (the “Registrant”), the undersigned hereby certifies that to the best of his knowledge:
1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Date: March 30, 2017 | /s/ George Carpenter |
George Carpenter | |
Chief Executive Officer (Principal Executive Officer) | |
Date: March 30, 2017 | /s/ Paul Buck |
Paul Buck | |
Chief Financial Officer (Principal Financial Officer) |